Product Families

icon: upicon: down
Sort by

NOBIVAC® Edge Lepto 4

NOBIVAC EDGE LEPTO4 Vaccine is the only canine leptospirosis vaccine with two critical indications, available in 0.5 mL dose.

icon: arrow-rightLEARN MORE

NOBIVAC® Edge DAPPv+L4

NOBIVAC EDGE DAPPv+L4 provides proven protection against several common viruses and enhanced quality in leptospirosis protection.

icon: arrow-rightLEARN MORE

NOBIVAC EDGE® DAPPv

Approved for protection of healthy dogs against canine distemper, adenovirus (Type 1), CPIV and CPV.

icon: arrow-rightLEARN MORE

REVALOR®-G

REVALOR® -G is used in more stocker cattle than any other brand. In fact, it leads the next closest implant brand by a more than 2-to-1 margin.

icon: arrow-rightLEARN MORE

REVALOR®-200

As part of an aggressive implant strategy, REVALOR® -200 increases rate of gain and improves feed efficacy in feedlot cattle.

icon: arrow-rightLEARN MORE

BANAMINE®-S (flunixin meglumine injection)

For the control of pyrexia associated with swine respiratory disease.

icon: arrow-rightLEARN MORE

BANAMINE® TRANSDERMAL

Indicated for the control of fever associated with BRD, bovine mastitis and pain associated with foot rot. The first and only NSAID cattle…

icon: arrow-rightLEARN MORE

BANAMINE® (flunixin meglumine paste)

BANAMINE® (flunixin meglumine paste) is a trusted and effective treatment for musculoskeletal disorders in horses. Learn more about its uses.

icon: arrow-rightLEARN MORE

Banamine®

Indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis in cattle.

icon: arrow-rightLEARN MORE

Nobivac® Puppy-DPv

For the vaccination of healthy puppies for the prevention of disease caused by canine distemper virus and CPV.

icon: arrow-rightLEARN MORE

Nobivac® NXT FeLV

First and only non-adjuvanted feline leukemia virus (FeLV) vaccine built on RNA particle technology

icon: arrow-rightLEARN MORE

Nobivac® NXT Canine Flu H3N2

First and only canine flu vaccine built on RNA particle technology

icon: arrow-rightLEARN MORE